When settled, the transaction will reduce Italy's stake in MPS, the world's oldest bank, to 11.7% from 26.7%. "We completed a transaction which strengthens the shareholder base of an important ...

A possible new force in Italian banking has begun to take shape, after regional lender Banco BPM SpA took a major stake in rival Banca Monte dei Paschi di Siena SpA. Banco BPM on Wednesday snapped ...

Govt placed 15% of bailed-out MPS for 1.1 bln euros Rival Banco BPM took 5%, fund manager Anima 3% Banco BPM has bid to buy Anima - also an MPS partner Italy spent 7 bln euros on MPS, has cashed ...

ROME (Reuters) -Italy on Wednesday raised 1.1 billion euros ($1.16 billion) by selling 15% of bailed-out bank Monte dei Paschi di Siena (MPS), bringing on board rival Banco BPM as a shareholder in ...

The original EU deadline for privatisation was extended after a failed sale to UniCredit in 2021 "Italy sells 15% stake in Monte dei Paschi stake for $1.16bn " was originally created and published ...

MILAN (Reuters) - Italy is struggling to find a "strategic" buyer for its stake in lender Monte dei Paschi di Siena before a year-end deadline, leaving it with little alternative but to turn to ...

Having restructured under Lovaglio after a 2017 bailout and a 2022 cash call, Monte dei Paschi has begun benefitting from DTAs accumulated during years of steep losses. But Italy intends to ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. What’s the buzz? Casa Monti is the first Italian foray for Leitmotiv, the family-owned group behind Cœur ...

Don’t stop Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after signing a deal with Novartis to the tune of $150 million for a molecular glue degrader, developed using ...

Maybe that’s why he was great at them. Fortunately, at this point, Monti — as he likes to be called — has narrowed his concentration to one exclusive thing that he does well. He makes grinders.

The molecular glue degrader medicines furthest along in development are potential cancer treatments, but Monte Rosa Therapeutics is also researching how this therapeutic modality can treat ...